10 Best Stocks to Buy in 2026 According to Billionaire D.E. Shaw

7. Boston Scientific Corporation (NYSE:BSX)

D. E. Shaw’s Q1 2026 Stake: $1.5 billion 

Boston Scientific Corporation (NYSE:BSX) is one of the largest medical device companies in America. Its shares are down by 56% over the past year and by 52% year-to-date. Jefferies was out with a devastating note about the firm as it slashed the share price target to $67 from $100 and kept a Buy rating on the stock. Jefferies commented that a major dip in its US Watchman sales growth forecast to 5% from 14% plaed a major role in its coverage for Boston Scientific Corporation (NYSE:BSX). The Watchman is a heart implant used to prevent strokes and blood clots in people with heart valve problems. Jefferies outlined that it was wary about the market adoption of the Watchman FLX device.

Earlier in the month, Bank of America had reduced Boston Scientific Corporation (NYSE:BSX)’s share price target to $61 from $68 and kept a Buy rating on the stock. A lower utilization for the firm’s devices played a role in BofA’s coverage. Earlier in the year, Boston Scientific Corporation (NYSE:BSX) made a move into the aortic stenosis market as it invested $1.5 billion in MiRus LLC in order to secure rights to the target’s TAVR system.